Regeneron Pharmaceuticals Inc. Stock Outperforms Market On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) rallied 3.41% to $633.96 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.13% to 3,930.08 and Dow Jones Industrial Average falling 0.33% to 31,730.30. Regeneron Pharmaceuticals Inc. closed $113.46 short of its 52-week high ($747.42), which the company reached on April 8th.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 0.99% to $177.87, Novartis AG ADR (NOVN.EB) rose 1.59% to $85.38, and Amgen Inc. (AMGN) rose 1.70% to $244.72. Trading volume (793,141) eclipsed its 50-day average volume of 662,679.
Data source: Dow Jones Market Data, FactSet. Data compiled May 12, 2022.
(END) Dow Jones Newswires
May 12, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.